WallStreetZenWallStreetZen

NYSE: PBH
Prestige Consumer Healthcare Inc Stock

$71.80+1.15 (+1.63%)
Updated Jul 16, 2024
PBH Price
$71.80
Fair Value Price
N/A
Market Cap
$3.58B
52 Week Low
$56.34
52 Week High
$75.31
P/E
17.05x
P/B
2.17x
P/S
3.21x
PEG
2.99x
Dividend Yield
N/A
Revenue
$1.13B
Earnings
$209.34M
Gross Margin
55.5%
Operating Margin
30.5%
Profit Margin
18.6%
Debt to Equity
1.01
Operating Cash Flow
$249M
Beta
0.62
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

PBH Overview

Prestige Consumer Healthcare Inc. manufactures over-the-counter health and personal care products in the U.S. and internationally. Offerings include BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. It sells its products through mass merchandisers, and drug, food, dollar, convenience, and club stores, as well as online. Prestige Consumer Healthcare was founded in 1996 and is headquartered in Tarrytown, NY.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PBH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PBH ($71.80) is trading above its intrinsic value of $31.51, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PBH is good value based on its earnings relative to its share price (17.05x), compared to the US market average (31.71x)
P/E vs Market Valuation
PBH is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PBH due diligence checks available for Premium users.

Be the first to know about important PBH news, forecast changes, insider trades & much more!

PBH News

Valuation

PBH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
17.05x
Industry
-1.36x
Market
31.71x
PBH is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PBH is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

PBH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.17x
Industry
2.27x
PBH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PBH price to earnings growth (PEG)

For valuing profitable companies with growth potential
PBH is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

PBH's financial health

Profit margin

Revenue
$277.0M
Net Income
$49.5M
Profit Margin
17.9%
PBH's Earnings (EBIT) of $343.19M... subscribe to Premium to read more.
Interest Coverage Financials
PBH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.3B
Liabilities
$1.7B
Debt to equity
1.01
PBH's short-term assets ($375.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PBH's long-term liabilities ($1.55B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PBH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PBH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$66.9M
Investing
-$15.0M
Financing
-$68.4M
PBH's operating cash flow ($248.93M)... subscribe to Premium to read more.
Debt Coverage Financials

PBH vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
PBH$3.58B+1.63%17.05x2.17x
PRGO$3.69B+0.71%-451.50x0.79x
HCM$3.25B-0.27%31.08x4.45x
ALVO$3.24B+0.33%-5.84x-4.92x
ALKS$4.16B+5.26%9.39x3.32x

Prestige Consumer Healthcare Stock FAQ

What is Prestige Consumer Healthcare's quote symbol?

(NYSE: PBH) Prestige Consumer Healthcare trades on the NYSE under the ticker symbol PBH. Prestige Consumer Healthcare stock quotes can also be displayed as NYSE: PBH.

If you're new to stock investing, here's how to buy Prestige Consumer Healthcare stock.

What is the 52 week high and low for Prestige Consumer Healthcare (NYSE: PBH)?

(NYSE: PBH) Prestige Consumer Healthcare's 52-week high was $75.31, and its 52-week low was $56.34. It is currently -4.66% from its 52-week high and 27.43% from its 52-week low.

How much is Prestige Consumer Healthcare stock worth today?

(NYSE: PBH) Prestige Consumer Healthcare currently has 49,915,366 outstanding shares. With Prestige Consumer Healthcare stock trading at $71.80 per share, the total value of Prestige Consumer Healthcare stock (market capitalization) is $3.58B.

Prestige Consumer Healthcare stock was originally listed at a price of $17.75 in Feb 10, 2005. If you had invested in Prestige Consumer Healthcare stock at $17.75, your return over the last 19 years would have been 304.51%, for an annualized return of 7.63% (not including any dividends or dividend reinvestments).

How much is Prestige Consumer Healthcare's stock price per share?

(NYSE: PBH) Prestige Consumer Healthcare stock price per share is $71.80 today (as of Jul 16, 2024).

What is Prestige Consumer Healthcare's Market Cap?

(NYSE: PBH) Prestige Consumer Healthcare's market cap is $3.58B, as of Jul 17, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Prestige Consumer Healthcare's market cap is calculated by multiplying PBH's current stock price of $71.80 by PBH's total outstanding shares of 49,915,366.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.